A Multi-center Phase II Study of Selective Depletion of CD45RA+ T Cells from Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD May 5, 2022 By Jesse Bufkin
SECURE: A Non-Interventional Long-term Post-Marketing Registry of Patients Treated with Certolizumab Pegol (Cimzia®) for Crohn’s Disease May 5, 2022 By Jesse Bufkin
Descending Thoracic Aortic Aneurysm Endovascular Repair Post Approval Study May 5, 2022 By Jesse Bufkin
A Clinical Evaluation of the GORE TAG Thoracic Endoprosthesis in the Primary Treatment of Descending Thoracic Aortic Aneurysms May 5, 2022 By Jesse Bufkin
CLINICAL INVESTIGATION PLAN FOR THE ZENITH® LOW PROFILE AAA ENDOVASCULAR GRAFT May 5, 2022 By Jesse Bufkin
Phase I-II Study of Doxil® in Combination with Daily Oral Cyclophosphamide and Herceptin in Patients with HER-2/neu Positive Disease in Patients with Metastatic Breast Cancer May 5, 2022 By Jesse Bufkin
Bortezomib and Vorinostat as Maintenance Therapy after Autologous Transplant for Non-Hodgkin’s Lymphoma May 5, 2022 By Jesse Bufkin
